You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -1.1 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 0.0 | n/a |
Price / Book value | 1.2 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | n/a | -2.72 | -4,135.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | n/a | -1.54 | -3.81p | -5.1 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | n/a | -1.68 | -2.34p | -15.5 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | n/a | -2.60 | -3.06p | -4.6 | 0.0 | n/a | n/a | 0.0% |
ValiRx inks deal with Dundee Drug Discovery Unit Sharecast News | 12 Feb |
---|---|
ValiRx enters option deal with Ambrose Healthcare Sharecast News | 05 Dec |
ValiRx enters partnership with StingRay Bio Sharecast News | 10 Nov |
Directorate Changes | 22-Apr-24 07:01 |
---|---|
Evaluation Agreement with Imperial College London | 21-Mar-24 09:14 |
Board Re-structuring and update on requisition | 19-Mar-24 07:01 |
Shareholder Requisition Notice | 04-Mar-24 17:48 |
Proposed Appointment of Non-Executive Director | 04-Mar-24 07:00 |